Eluryng and Stress and anxiety - a phase IV clinical study of FDA data

Summary:

Stress and anxiety is reported as a side effect among people who take Eluryng (ethinyl estradiol; etonogestrel), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Nuvaring, and have Heavy or prolong menstrual bleeding.

The phase IV clinical study analyzes which people have Stress and anxiety when taking Eluryng. It is created by eHealthMe based on reports of 655 people who have side effects when taking Eluryng from the FDA, and is updated regularly.

What is Eluryng?

Eluryng has active ingredients of ethinyl estradiol; etonogestrel. It is often used in birth control. eHealthMe is studying from 662 Eluryng users. Check the latest studies of Eluryng.

What is Stress and anxiety?

Stress and anxiety is found to be associated with 3,541 drugs and 5,489 conditions by eHealthMe. Check the latest studies of Stress and anxiety.

On Apr, 17, 2026

655 people reported to have side effects when taking Eluryng.
Among them, 23 people (3.51%) have Stress and anxiety.

Among these 23 people:

How long have people been on Eluryng when they have Stress and anxiety? *

What is the gender of people who have Stress and anxiety when taking Eluryng? *

female: 100 %
male: 0.0 %

What is the age of people who have Stress and anxiety when taking Eluryng? *

What are other drugs people take besides Eluryng? *

What are other side effects people have besides Stress and anxiety? *

Depression: 11 people, 47.83%
Mood Swings (an extreme or rapid change in mood): 10 people, 43.48%
Insomnia (sleeplessness): 7 people, 30.43%
Headache (pain in head): 7 people, 30.43%
Nausea (feeling of having an urge to vomit): 7 people, 30.43%
Panic Disorder: 7 people, 30.43%
Fatigue (feeling of tiredness): 6 people, 26.09%
Migraine (headache): 5 people, 21.74%
Weight Increased: 5 people, 21.74%
Abdominal Distension: 5 people, 21.74%

What are the existing conditions these people have? *

Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 1 person, 4.35%
Pain: 1 person, 4.35%
Heavy Or Prolong Menstrual Bleeding: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Eluryng and have Stress and anxiety?

- Check whether Stress and anxiety is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eluryng:

Eluryng (662 reports)

Stress and anxiety treatments and more:

Stress and anxiety (637,432 reports)

How severe was Stress and anxiety and when was it recovered:

Stress and anxiety in Eluryng

Expand to all the drugs that have ingredients of ethinyl estradiol; etonogestrel:

Stress and anxiety and drugs with ingredients of ethinyl estradiol; etonogestrel (1,768 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Eluryng:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stress and anxiety:

Stress and anxiety (3,541 drugs)

Browse all the conditions that are associated with Stress and anxiety:

Stress and anxiety (5,489 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; etonogestrel (the active ingredients of Eluryng) and Eluryng (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.